Monothioglycerol
Star0
Identification
- Generic Name
- Monothioglycerol
- DrugBank Accession Number
- DB03864
- Background
Not Available
- Type
- Small Molecule
- Groups
- Experimental
- Structure
- Weight
- Average: 108.159
Monoisotopic: 108.02450019 - Chemical Formula
- C3H8O2S
- Synonyms
- Not Available
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Contraindications & Blackbox Warnings
- Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API
- Pharmacodynamics
Not Available
- Mechanism of action
Target Actions Organism UProlyl endopeptidase Not Available Humans - Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
- Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.
- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs Browse all" title="About SNP Mediated Effects/ADRs" id="snp-actions-info" class="drug-info-popup" href="javascript:void(0);">
- Not Available
Interactions
- Drug Interactions Learn More" title="About Drug Interactions" id="structured-interactions-info" class="drug-info-popup" href="javascript:void(0);">
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- Not Available
Categories
- Drug Categories
- Chemical TaxonomyProvided by Classyfire
- Description
- This compound belongs to the class of organic compounds known as 1,2-diols. These are polyols containing an alcohol group at two adjacent positions.
- Kingdom
- Organic compounds
- Super Class
- Organic oxygen compounds
- Class
- Organooxygen compounds
- Sub Class
- Alcohols and polyols
- Direct Parent
- 1,2-diols
- Alternative Parents
- Secondary alcohols / Alkylthiols / Primary alcohols / Hydrocarbon derivatives
- Substituents
- 1,2-diol / Aliphatic acyclic compound / Alkylthiol / Hydrocarbon derivative / Organosulfur compound / Primary alcohol / Secondary alcohol
- Molecular Framework
- Aliphatic acyclic compounds
- External Descriptors
- monothioglycerol (CHEBI:45619)
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- AAO1P0WSXJ
- CAS number
- Not Available
- InChI Key
- PJUIMOJAAPLTRJ-GSVOUGTGSA-N
- InChI
- InChI=1S/C3H8O2S/c4-1-3(5)2-6/h3-6H,1-2H2/t3-/m1/s1
- IUPAC Name
- (2R)-3-sulfanylpropane-1,2-diol
- SMILES
- OC[C@@H](O)CS
References
- General References
- Not Available
- External Links
- PubChem Compound
- 447638
- PubChem Substance
- 46508507
- ChemSpider
- 394673
- 1363062
- ChEBI
- 45619
- ZINC
- ZINC000003860581
- PDBe Ligand
- SGM
- Wikipedia
- 3-Mercaptopropane-1,2-diol
- PDB Entries
- 1ogu / 1oi9 / 1oiu / 1oiy / 1qfm / 2iw6 / 2iw8 / 2iw9 / 3bht / 3bhv … show 26 more
Clinical Trials
- Clinical Trials Learn More" title="About Clinical Trials" id="clinical-trials-info" class="drug-info-popup" href="javascript:void(0);">
Phase Status Purpose Conditions Count
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
- Not Available
- Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Solid
- Experimental Properties
- Not Available
- Predicted Properties
Property Value Source Water Solubility 40.5 mg/mL ALOGPS logP -0.29 ALOGPS logP -0.74 Chemaxon logS -0.43 ALOGPS pKa (Strongest Acidic) 9.92 Chemaxon pKa (Strongest Basic) -2.9 Chemaxon Physiological Charge 0 Chemaxon Hydrogen Acceptor Count 2 Chemaxon Hydrogen Donor Count 3 Chemaxon Polar Surface Area 40.46 Å2 Chemaxon Rotatable Bond Count 2 Chemaxon Refractivity 26.7 m3·mol-1 Chemaxon Polarizability 10.98 Å3 Chemaxon Number of Rings 0 Chemaxon Bioavailability 1 Chemaxon Rule of Five Yes Chemaxon Ghose Filter No Chemaxon Veber's Rule No Chemaxon MDDR-like Rule No Chemaxon - Predicted ADMET Features
Property Value Probability Human Intestinal Absorption + 0.9477 Blood Brain Barrier + 0.5223 Caco-2 permeable - 0.7244 P-glycoprotein substrate Non-substrate 0.7678 P-glycoprotein inhibitor I Non-inhibitor 0.9214 P-glycoprotein inhibitor II Non-inhibitor 0.9712 Renal organic cation transporter Non-inhibitor 0.9323 CYP450 2C9 substrate Non-substrate 0.8748 CYP450 2D6 substrate Non-substrate 0.8603 CYP450 3A4 substrate Non-substrate 0.7934 CYP450 1A2 substrate Non-inhibitor 0.5963 CYP450 2C9 inhibitor Non-inhibitor 0.9236 CYP450 2D6 inhibitor Non-inhibitor 0.9456 CYP450 2C19 inhibitor Non-inhibitor 0.8876 CYP450 3A4 inhibitor Non-inhibitor 0.9676 CYP450 inhibitory promiscuity Low CYP Inhibitory Promiscuity 0.9087 Ames test Non AMES toxic 0.8612 Carcinogenicity Non-carcinogens 0.6626 Biodegradation Ready biodegradable 0.6177 Rat acute toxicity 2.0414 LD50, mol/kg Not applicable hERG inhibition (predictor I) Weak inhibitor 0.9613 hERG inhibition (predictor II) Non-inhibitor 0.8859
Spectra
- Mass Spec (NIST)
- Not Available
- Spectra
Spectrum Spectrum Type Splash Key Predicted GC-MS Spectrum - GC-MS Predicted GC-MS splash10-000t-9000000000-4cd9f73750a06fa23948 Predicted MS/MS Spectrum - 10V, Positive (Annotated) Predicted LC-MS/MS splash10-052f-9000000000-7fd377ac7e3009f44586 Predicted MS/MS Spectrum - 10V, Negative (Annotated) Predicted LC-MS/MS splash10-0a4r-9700000000-a95ee51beae2e5646e9b Predicted MS/MS Spectrum - 20V, Positive (Annotated) Predicted LC-MS/MS splash10-0a4i-9000000000-32abe4cb225e13482f00 Predicted MS/MS Spectrum - 20V, Negative (Annotated) Predicted LC-MS/MS splash10-001i-9000000000-ff88c355419302411e58 Predicted MS/MS Spectrum - 40V, Positive (Annotated) Predicted LC-MS/MS splash10-0002-9000000000-84f4677c052ff67c9cd1 Predicted MS/MS Spectrum - 40V, Negative (Annotated) Predicted LC-MS/MS splash10-001i-9000000000-49e39c60f488c3dfb98e Predicted 1H NMR Spectrum 1D NMR Not Applicable Predicted 13C NMR Spectrum 1D NMR Not Applicable - Chromatographic Properties
Collision Cross Sections (CCS)
Adduct CCS Value (Å2) Source type Source [M-H]- 111.9899577 predictedDarkChem Lite v0.1.0 [M-H]- 122.61537 predictedDeepCCS 1.0 (2019) [M+H]+ 112.4790577 predictedDarkChem Lite v0.1.0 [M+H]+ 124.537674 predictedDeepCCS 1.0 (2019) [M+Na]+ 112.3073577 predictedDarkChem Lite v0.1.0 [M+Na]+ 132.26678 predictedDeepCCS 1.0 (2019)
Targets
Build, predict & validate machine-learning models
Use our structured and evidence-based datasets to unlock newinsights and accelerate drug research.
Use our structured and evidence-based datasets to unlock new insights and accelerate drug research.
1. DetailsProlyl endopeptidase
- Kind
- Protein
- Organism
- Humans
- Pharmacological action
- Unknown
- General Function
- Serine-type peptidase activity
- Specific Function
- Cleaves peptide bonds on the C-terminal side of prolyl residues within peptides that are up to approximately 30 amino acids long.
- Gene Name
- PREP
- Uniprot ID
- P48147
- Uniprot Name
- Prolyl endopeptidase
- Molecular Weight
- 80698.945 Da
References
- Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6. [Article]
- Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34. [Article]
- Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. [Article]
Drug created at June 13, 2005 13:24 / Updated at June 12, 2020 16:52